Results
1
-
1
of
1
Targeting CD56 (NCAM)-Expressing Neoplasms with Lorvotuzumab Mertansine
,
Antibody-Drug Conjugates and Immunotoxins
[DOI: 10.1007/978-1-4614-5456-4_16]